Lynd Clinical is a purpose-built clinical research site network that brings clinical trials directly to rural and community America, with initial sites launching across Mississippi, Arkansas, and Alabama. The company partners with leading U.S. health systems and uses a proprietary AI platform that analyzes longitudinal medical records to match patients with protocol-specific criteria, enabling faster enrollment and high-quality trial execution across therapeutic areas including metabolic disorders, cardiovascular disease, neurology, and psychiatry.
Funding
Funding not disclosed
Founders
Product
Problem
Rural and community populations in the U.S. have limited access to clinical research trials, as most research sites are concentrated in urban academic medical centers. This geographic gap creates disparities in healthcare innovation, slows patient recruitment, and delays the development of treatments that reflect diverse real-world populations.
Solution
Lynd Clinical designs, builds, scales, and operates a network of fully owned clinical research sites in underserved rural and community areas, partnering directly with leading U.S. health systems, including one of the nation’s largest and regional provider groups. The company’s proprietary AI platform analyzes longitudinal electronic medical records to systematically match patients against protocol-specific inclusion and exclusion criteria, enabling precise identification, screening, and enrollment of high-quality participants. With a repeatable operational model that spans site selection, EHR-level data integration, compliance, and audit readiness, Lynd accelerates trial enrollment and execution while extending research access to regions historically excluded from clinical development.
Target Audience
Primary customers are U.S. health systems and provider groups seeking to expand clinical research capacity, as well as pharmaceutical and biotechnology sponsors looking for faster patient enrollment and access to underserved rural populations.
Features
- Proprietary AI platform that performs longitudinal medical record analysis and protocol-specific patient matching for precision screening and enrollment
- Purpose-built physical research sites and selective acquisition of existing sites integrated into a unified, performance-driven network
- Capabilities across high-demand therapeutic areas, including metabolic/endocrine disorders, cardiovascular disease, neurology, psychiatry, GI, hepatic disorders, pulmonary dysfunction, general medicine, and vaccines/infectious disease
- Integrated health-system partnerships that provide EHR-level insight and access to patient populations beyond traditional research channels
- Full-service execution model emphasizing compliance, audit readiness, and clean data delivery at every trial stage
- Scalable operational playbook enabling rapid expansion into new rural markets with consistent performance outcomes